Related Experiment Video
Updated: Nov 3, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Decision models in type 2 diabetes mellitus: A systematic review
Jiayu Li1,2,3, Yun Bao2, Xuedi Chen1,2
1Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, 730000, Gansu Province, China.
This review summarizes 14 type 2 diabetes (T2DM) decision models, highlighting their varied characteristics and complexities. Future models should balance detail with transparency for better decision-making in T2DM management.
Area of Science:
- Health economics
- Epidemiology
- Biostatistics
Background:
- Type 2 diabetes (T2DM) poses a significant global health burden.
- Disease decision models are crucial tools for informing T2DM management strategies.
- A comprehensive assessment of existing T2DM decision models is lacking.
Purpose of the Study:
- To provide an overview of the characteristics and capabilities of published T2DM decision models.
- To assess the suitability of different models for various research needs.
- To guide the selection and development of T2DM decision models.
Main Methods:
- Systematic literature search of four databases (PubMed, Web of Science, Embase, Cochrane Library) up to August 2020.
- Inclusion of studies using keywords related to T2DM, cost-utility, quality-of-life, and decision models.
- Independent screening and data extraction by two reviewers, focusing on model characteristics, methodologies, inputs, outcomes, validation, and uncertainty.
Main Results:
- Fourteen unique T2DM decision models were identified, employing diverse methodologies like Markov chains and risk equations.
- Most models used annual cycles and flexible time horizons, with 10 focusing on complications and 11 on patient-level simulations.
- Eleven models simulated annual risk factor changes, and most addressed model uncertainty and validation.
Conclusions:
- T2DM decision models exhibit significant heterogeneity in health state classification detail.
- Balancing model complexity with transparency is essential for effective T2DM decision model development.
- Further research should focus on standardizing or clearly defining model structures for improved comparability.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

